SAN ANTONIO — Cisplatin plus radiation therapy should remain the standard of care for human papillomavirus (HPV)-positive oropharyngeal cancer, according to new findings from a major randomized phase ...
Phase III trial of capecitabine + oxaliplatin (XELOX) vs. 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (FOLFOX4) as 2nd-line treatment for patients with metastatic colorectal cancer (MCRC) ...
Vol. 4, No. 5, Second Annual Meeting of the International Society for Quality of Life Research: Abstracts of the Contributed Papers (Oct., 1995), p. 483 (1 page) Quality of Life Research is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback